Stock listing

Xortx Therapeutics, Inc.

Selected listing: XRTX · TSXV · CAD · CA

Xortx Therapeutics, Inc. (TSXV:XRTX), Health Technology. Latest release Sep 18, 2026: XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program…

XRTX:TSXVCADCAUpdated August 31, 2026

Ticker: TSXV:XRTX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: TSXV
Currency: CAD

About Xortx Therapeutics, Inc.

Xortx Therapeutics, Inc. is a public company traded on the Canadian market under the ticker XRTX. Xortx focuses on developing therapies for kidney diseases and related conditions.

Latest news from Xortx Therapeutics, Inc.

XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO(TM), Targeting USD$700M+ U.S. Gout Market Opportunity

September 18, 2026

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO(TM)

September 10, 2026

XORTX Re-Engages Investor Relations Program

September 8, 2026

XORTX Announces Termination and Postponement of Investor Relations Program

August 28, 2026

XORTX Announces Director Resignation

July 31, 2026

All Xortx Therapeutics, Inc. news →

Research Xortx Therapeutics, Inc.

Xortx Therapeutics, Inc. company profile

View the public company page for Xortx Therapeutics, Inc. on 6ix.

Xortx Therapeutics, Inc. news

Read company news and market updates connected to Xortx Therapeutics, Inc..

Xortx Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Xortx Therapeutics, Inc..